QQQ   375.08 (+0.65%)
AAPL   148.42 (+1.28%)
MSFT   308.09 (+0.26%)
FB   339.36 (+1.20%)
GOOGL   2,856.89 (+0.05%)
TSLA   871.09 (+0.11%)
AMZN   3,427.11 (-0.57%)
NVDA   223.50 (+0.58%)
BABA   173.45 (+3.97%)
NIO   39.97 (+0.91%)
CGC   13.46 (+1.97%)
GE   104.92 (+0.77%)
AMD   116.97 (+0.46%)
MU   67.25 (-0.01%)
T   25.44 (+0.43%)
F   15.58 (+0.13%)
ACB   6.96 (+0.58%)
DIS   170.78 (-0.21%)
PFE   42.06 (+1.79%)
BA   216.26 (-0.33%)
AMC   42.66 (-0.86%)
QQQ   375.08 (+0.65%)
AAPL   148.42 (+1.28%)
MSFT   308.09 (+0.26%)
FB   339.36 (+1.20%)
GOOGL   2,856.89 (+0.05%)
TSLA   871.09 (+0.11%)
AMZN   3,427.11 (-0.57%)
NVDA   223.50 (+0.58%)
BABA   173.45 (+3.97%)
NIO   39.97 (+0.91%)
CGC   13.46 (+1.97%)
GE   104.92 (+0.77%)
AMD   116.97 (+0.46%)
MU   67.25 (-0.01%)
T   25.44 (+0.43%)
F   15.58 (+0.13%)
ACB   6.96 (+0.58%)
DIS   170.78 (-0.21%)
PFE   42.06 (+1.79%)
BA   216.26 (-0.33%)
AMC   42.66 (-0.86%)
QQQ   375.08 (+0.65%)
AAPL   148.42 (+1.28%)
MSFT   308.09 (+0.26%)
FB   339.36 (+1.20%)
GOOGL   2,856.89 (+0.05%)
TSLA   871.09 (+0.11%)
AMZN   3,427.11 (-0.57%)
NVDA   223.50 (+0.58%)
BABA   173.45 (+3.97%)
NIO   39.97 (+0.91%)
CGC   13.46 (+1.97%)
GE   104.92 (+0.77%)
AMD   116.97 (+0.46%)
MU   67.25 (-0.01%)
T   25.44 (+0.43%)
F   15.58 (+0.13%)
ACB   6.96 (+0.58%)
DIS   170.78 (-0.21%)
PFE   42.06 (+1.79%)
BA   216.26 (-0.33%)
AMC   42.66 (-0.86%)
QQQ   375.08 (+0.65%)
AAPL   148.42 (+1.28%)
MSFT   308.09 (+0.26%)
FB   339.36 (+1.20%)
GOOGL   2,856.89 (+0.05%)
TSLA   871.09 (+0.11%)
AMZN   3,427.11 (-0.57%)
NVDA   223.50 (+0.58%)
BABA   173.45 (+3.97%)
NIO   39.97 (+0.91%)
CGC   13.46 (+1.97%)
GE   104.92 (+0.77%)
AMD   116.97 (+0.46%)
MU   67.25 (-0.01%)
T   25.44 (+0.43%)
F   15.58 (+0.13%)
ACB   6.96 (+0.58%)
DIS   170.78 (-0.21%)
PFE   42.06 (+1.79%)
BA   216.26 (-0.33%)
AMC   42.66 (-0.86%)
NASDAQ:RGEN

Repligen Earnings Date, Estimates, & History

$269.09
+5.31 (+2.01 %)
(As of 10/19/2021 11:52 AM ET)
Add
Compare
Today's Range
$263.78
$269.60
50-Day Range
$249.64
$324.21
52-Week Range
$162.29
$327.32
Volume1,933 shs
Average Volume389,895 shs
Market Capitalization$14.77 billion
P/E Ratio150.33
Dividend YieldN/A
Beta0.9

Earnings Summary

Upcoming
Earnings Date
Oct. 28
Confirmed

Actual EPS
(Jul. 26)
$0.79
Beat By $0.27

Consensus EPS
(Jul. 26)
$0.52

Last Year's Q3 EPS
(7/30/2020)
$0.42

Skip Charts & View Estimated and Actual Earnings Data

Repligen Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

Repligen Estimated Revenue and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Repligen (NASDAQ:RGEN) Earnings Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateCompany Guidance
Q1 20214$0.38$0.43$0.41 
Q2 20214$0.52$0.56$0.54 
Q3 20214$0.63$0.66$0.65 
Q4 20214$0.63$0.65$0.64 
FY 202116$2.16$2.30$2.24
Q1 20223$0.62$0.76$0.69 
Q2 20223$0.74$0.93$0.82 
Q3 20223$0.75$0.78$0.77 
Q4 20223$0.77$0.80$0.79 
FY 202212$2.88$3.27$3.07

RGEN Earnings Information

Repligen last released its quarterly earnings results on July 26th, 2021. The biotechnology company reported $0.79 EPS for the quarter, beating analysts' consensus estimates of $0.52 by $0.27. The business earned $162.96 million during the quarter, compared to analyst estimates of $144.24 million. Its quarterly revenue was up 86.3% compared to the same quarter last year. Repligen has generated $1.65 earnings per share over the last year ($1.79 diluted earnings per share) and currently has a price-to-earnings ratio of 150.3. Earnings for Repligen are expected to grow by 9.42% in the coming year, from $2.76 to $3.02 per share. Repligen has confirmed that its next quarterly earnings report will be published on Thursday, October 28th, 2021. Repligen will be holding an earnings conference call on Thursday, October 28th at 8:30 AM Eastern. Interested parties can register for or listen to the call. or dial in at 412-317-0088 with passcode "10161245".

Repligen (NASDAQ:RGEN) Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueActions
10/28/2021
(Confirmed)
 $0.64       
7/26/20216/30/2021$0.52$0.79+$0.27$0.94$144.24 million$162.96 million    
5/4/20213/31/2021$0.42$0.68+$0.26$0.84$117.88 million$142.80 million  
2/23/202112/31/2020$0.31$0.52+$0.21$0.68$93.89 million$108.65 million  
11/5/20209/30/2020$0.28$0.40+$0.12$0.53$86.45 million$94.10 million  
7/30/20206/30/2020$0.28$0.42+$0.14$0.54$78.11 million$87.46 million  
5/6/20203/31/2020$0.22$0.32+$0.10$0.46$71.79 million$76.09 million  
2/20/2020Q4 2019$0.18$0.20+$0.02$0.33$68.37 million$69.47 million  
10/31/2019Q3 2019$0.19$0.26+$0.07$0.49$66.10 million$69.45 million  
8/1/2019Q2 2019$0.25$0.31+$0.06$0.45$65.47 million$70.70 million  
5/9/20193/31/2019$0.26$0.28+$0.02$0.39$55.09 million$60.63 million  
2/21/201912/31/2018$0.21$0.21$0.30$50.27 million$51.90 million  
11/1/20189/30/2018$0.18$0.20+$0.02$0.30$46.69 million$49.53 million
8/2/2018Q2 2018$0.18$0.16($0.02)$0.26$45.84 million$47.73 million
5/8/2018Q1 2018$0.15$0.17+$0.02$0.26$43.88 million$44.80 million
2/22/2018Q4 2017$0.12$0.20+$0.08$0.13$41.13 million$41.60 million
11/9/2017Q3 2017$0.11$0.15+$0.04$0.19$35.69 million$36.58 million
8/3/2017Q2 2017$0.1480$0.20+$0.0520$0.16$31.72 million$32.40 million  
5/4/20173/31/2017$0.13$0.15+$0.02$0.21$29.28 million$30.59 million  
2/22/2017Q4 2016$0.07$0.08+$0.01$0.01$24.05 million$25.60 million  
11/3/2016Q3 2016$0.08$0.08$0.13$24.39 million$24.70 million
8/4/2016Q2 2016$0.13$0.16+$0.03$0.21$24.75 million$29.20 million
5/5/2016Q1 2016$0.14$0.12($0.02)$0.19$22.54 million$25.10 million
2/25/2016Q4 2015$0.08$0.07($0.01)$0.13$19.84 million$21.40 million  
11/5/2015Q3 2015$0.08$0.08$0.08$20.50 million$19.80 million
8/6/2015Q2 2015$0.10$0.11+$0.01$0.11$20.05 million$21.50 million
5/7/2015Q1 2015$0.08$0.09+$0.01$0.09$18.20 million$20.82 million
3/13/2015Q4 2014$0.04($0.01)($0.05)($0.01)$14.70 million$15.40 million
11/6/2014Q3 2014$0.05$0.04($0.01)$0.04$15.60 million$15.30 million
8/11/2014Q2 2014$0.06$0.09+$0.03$0.09$14.90 million$15.60 million
5/8/2014Q1 2014$0.09$0.13+$0.04$0.13$15.14 million$16.33 million  
3/6/2014Q4 2013$0.10+$0.10$0.10$15.88 million$10.40 million  
11/7/2013Q3 2013$0.18+$0.18$0.18$16.27 million$18.80 million  
8/1/2013Q2 2013$0.14+$0.14$0.14$15.97 million$17.50 million  
5/2/2013Q1 2013$0.07+$0.07$0.07$12.82 million$16.46 million  
3/7/2013Q4 2012$0.07$0.31+$0.24$0.32
11/8/2012Q312$0.06+$0.06$8.63 million$15.10 million  
8/2/2012Q2 2012$0.01$0.05+$0.04$0.05
5/3/2012Q1 2012$0.04+$0.04$0.04
3/16/2012Q4 2011($0.04)($0.07)($0.03)($0.07)
10/27/2011Q3 2011($0.02)$0.02+$0.04$0.02
6/9/2011Q1 2011($0.03)($0.06)($0.03)($0.06)
2/9/2011Q4 2010($0.03)$0.01+$0.04$0.01
11/2/2010Q3 2010($0.04)$0.02+$0.06$0.02
8/5/2010Q2 2010$0.03+$0.03$0.03
6/9/2010Q1 2010($0.05)($0.05)($0.05)
2/4/2010Q4 2009($0.04)($0.01)+$0.03($0.01)
11/5/2009Q3 2009($0.04)($0.03)+$0.01($0.03)
8/6/2009Q2 2009($0.04)($0.04)($0.04)
6/11/2009Q1 2009($0.06)($0.09)($0.03)($0.09)
8/7/2008Q2 2008$0.16$0.26+$0.10$0.26
6/12/2008Q1 2008($0.10)($0.10)($0.10)
2/7/2008Q4 2007($0.05)($0.01)+$0.04($0.01)
(Earnings results data provided by Zacks Investment Research)












Repligen (NASDAQ:RGEN) Earnings Frequently Asked Questions

When is Repligen's earnings date?

Repligen has confirmed that its next quarterly earnings data will be published on Thursday, October 28th, 2021. Learn more on RGEN's earnings history

Did Repligen beat their earnings estimates last quarter?

In the previous quarter, Repligen (NASDAQ:RGEN) reported $0.79 earnings per share (EPS) to beat the analysts' consensus estimate of $0.52 by $0.27. Learn more on RGEN's earnings details

How can I listen to Repligen's earnings conference call?

The conference call for Repligen's latest earnings report can be listened to online. Listen to Conference Call

How can I read Repligen's conference call transcript?

The conference call transcript for Repligen's latest earnings report can be read online. Read Transcript

How much revenue does Repligen generate each year?

Repligen (NASDAQ:RGEN) has a recorded annual revenue of $366.26 million.

How much profit does Repligen generate each year?

Repligen (NASDAQ:RGEN) has a recorded net income of $59.93 million. RGEN has generated $1.65 earnings per share over the last four quarters.

What is Repligen's price-to-earnings ratio?

Repligen (NASDAQ:RGEN) has a trailing price-to-earnings ratio of 150.33 and a forward price-to-earnings ratio of 97.50.

What is Repligen's EPS forecast for next year?

Repligen's earnings are expected to grow from $2.76 per share to $3.02 per share in the next year, which is a 9.42% increase.

This page was last updated on 10/19/2021 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.